Follow Us
© 2026 Arizent. All rights reserved.
Guest blogger Linda K. Riddell shows how an eye for detail and some simple calculations could prove to be a life-saver for employees that are overusing/abusing narcotic painkillers. As always, share your thoughts in the comments. —Kelley M. Butler
For reprint and licensing requests for this article, click here.
In addition to finding success with a self-funded model, an in-house program gives Fello's employees access to cost-free primary and urgent care.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
Rising use of the weight-loss drug is fueling the fastest health plan cost growth in a decade and a half, forcing employers to rethink coverage strategies and cost management.
